World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on September 22, 2026

Sep. 22, 2026

TRU47® and United Grid League Announce Strategic Partnership to Advance Athlete Performance, Recovery and Wellness

Indeterminate EIN Presswire

Sep. 22, 2026

Connecticut Sports Group Applauds $8 Million State Grant for Dodd Stadium Renovation

Indeterminate GlobeNewswire

Sep. 22, 2026

Applied Biologics Announces Last Patient, Last Visit in CAMPX Randomized Controlled Trial of XWRAP®

Indeterminate GlobeNewswire

Sep. 22, 2026

SK pharmteco und GEMMABio bauen ihre Zusammenarbeit im Bereich der Herstellung von Arzneimitteln für seltene Erkrankungen nach einem wichtigen Meilenstein in der klinischen Studie zur spinalen Muskelatrophie (SMA) aus

Indeterminate GlobeNewswire

Sep. 22, 2026

SK pharmteco et GEMMABio renforcent leur collaboration dans la fabrication de traitements pour les maladies rares après une étape clé de l’essai clinique consacré à l’amyotrophie spinale (SMA)

Indeterminate GlobeNewswire

Sep. 22, 2026

Zealand Pharma announces initiation of the registrational Phase 3 ZUPREME program of petrelintide in people with overweight or obesity

Indeterminate GlobeNewswire

Sep. 22, 2026

BANFIELD FOUNDATION RELEASES 2025 IMPACT REPORT CELEBRATING $3.4 MILLION IN GRANTS SUPPORTING UNDER-RESOURCED COMMUNITIES

Indeterminate GlobeNewswire

Sep. 22, 2026

Clear Gaze Capsules Introduces ClearGaze Multi-Ingredient Dietary Supplement for Daily Vision Support

Indeterminate GlobeNewswire

Sep. 22, 2026

Rendever Expands Dementia & Empathy Training With a New Mode for Family Caregivers

Indeterminate GlobeNewswire

Sep. 22, 2026

New York City Regional Center-Managed Entity Provides Funding for Urban Health Plan’s New Healthcare Facility in the South Bronx

Indeterminate GlobeNewswire

Sep. 22, 2026

Seek Labs Launches Open Impact Program at Clinton Global Initiative to Advance Therapeutic Development for Neglected Infectious Diseases

Indeterminate GlobeNewswire

Sep. 22, 2026

Ophirex Publishes Data from Phase 2 BRAVIO Trial Evaluating Intravenous Followed by Oral Varespladib for Snakebite

Indeterminate GlobeNewswire

Sep. 22, 2026

New Study Reveals When College Students at Risk for Suicide Begin to Improve in Virtual Therapy

Indeterminate GlobeNewswire

Sep. 22, 2026

Eclipse Energy and Wood Validate Pathway to Low-Cost, Ultra-Low-Carbon Hydrogen from Depleted Oil Reservoirs

Indeterminate GlobeNewswire

Sep. 22, 2026

Porch Light Health and CBHC Expand Access to Methadone Treatment in Northern Colorado

Indeterminate GlobeNewswire

Sep. 22, 2026

X-Chem Announces Phase 3 Milestone in Collaboration with Relay Therapeutics

Indeterminate GlobeNewswire

Sep. 22, 2026

Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways

Indeterminate GlobeNewswire

Sep. 22, 2026

SafeSpace Global Secures Up to $11 Million in Financing Capacity to Support Next Phase of Growth

Indeterminate GlobeNewswire

Sep. 22, 2026

TETmedical Strengthens Board of Directors with Appointment of Marc Lebel and Patrick McBrayer, Veteran Life Sciences Entrepreneurs and Company Builders

Indeterminate GlobeNewswire

Sep. 22, 2026

SK pharmteco and GEMMABio Expand Rare Disease Manufacturing Collaboration Following Important Spinal Muscular Atrophy (SMA) Clinical Trial Milestone

Indeterminate GlobeNewswire